Science Explorer Back to mapMap

Acute Lymphoblastic Leukemia research

Acute Lymphoblastic Leukemia research is a research topic within Public Health, Environmental and Occupational Health. Science Explorer counts 40k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, genetic basis, treatment, and outcomes of childhood acute lymphoblastic leukemia (ALL). It covers topics such as genetic alterations, minimal residual disease, pharmacogenomics, prognostic factors, and relapse risk. The papers also discuss the challenges and advancements in pediatric oncology for the treatment of childhood leukemia.

  • Childhood Cancer
  • Acute Lymphoblastic Leukemia
  • Genetic Alterations
  • Treatment Outcome
  • Minimal Residual Disease
  • Pharmacogenomics
  • Prognostic Factors
  • Thiopurine Therapy
  • Relapse Risk
  • Pediatric Oncology
Research works
40k
fractional, since 1950
In the world top 10%
4.1k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+20%
the tick is no change
Largest producer
United States
41% of the 10 largest, 2022-now
Acute Lymphoblastic Leukemia research
Drawing this view